Hilal Balta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hilal Balta has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Nevin Kocaman
Department of Histology and Embryology, Faculty of Medicine, Fırat University, Elazığ, Turkiye
3 shared publications - Ilknur Calik
Department of Pathology, Faculty of Medicine, Firat University
2 shared publications - Senay Erdogan-Durmus
Department of Pathology, Erzurum Region Training and Research Hospital, Erzurum, Turkey
2 shared publications - Sevilay Özmen
Department of Pathology, Faculty of Medicine, Ataturk University, Erzurum, Turkey
2 shared publications - Özlem Üçer
Department of Pathology, Firat University Hospital
2 shared publications - Ahmet Bilici
Department of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34214, Türkiye
1 shared publication
Latest Publications
- Open Access
- 15 October 2025
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 22 (4) , 292-298
Comparison of asprosin immunoreactivity in endometrial hyperplasia and grade-1 endometrial adenocarcinoma: A retrospective case-control study
Comparison of asprosin immunoreactivity in endometrial hyperplasia and grade-1 endometrial adenocarcinoma: A retrospective case-control study - Turkish Journal of Obstetrics and Gynecology
- 15 October 2025
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 22 (4) , 292-298
Open AccessComparison of asprosin immunoreactivity in endometrial hyperplasia and grade-1 endometrial adenocarcinoma: A retrospective case-control study
Comparison of asprosin immunoreactivity in endometrial hyperplasia and grade-1 endometrial adenocarcinoma: A retrospective case-control study - Turkish Journal of Obstetrics and Gynecology
- 2 October 2025
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 44 (4) , 579-586
Identification of human papillomavirus, Epstein–Barr virus and cytomegalovirus in paraffin tissues by molecular methods in patients with anogenital warts
Anogenital warts (AGWs) are typically caused by low-risk HPV types. Coinfection with EBV and CMV may influence disease progression, especially under immunosuppression. This study aimed to detect HPV, EBV, and CMV in tissue samples from AGW patients. This descriptive, retrospective, single-center study aimed to detect HPV, EBV, and CMV DNA in paraffin-embedded tissue samples from patients with AGWs. Paraffin-embedded tissues from 24 AGW patients were analyzed using real-time PCR and pyrosequencing for HPV, EBV, and CMV DNA. Demographic and viral data were statistically evaluated. Degraded or insufficient DNA samples were excluded following quality control assessment. Descriptive and comparative statistical analyses were performed using SPSS v22.0. HPV was detected in 62.5% of patients, most commonly type 6, followed by types 40, 87, and 16. EBV was found in 2 patients (8.3%), both with HPV coinfection. HPV. CMV was not detected in any samples. No statistically significant associations were found between demographic or clinical parameters and viral positivity. The study identified rare EBV and HPV coinfections in AGWs but no CMV positivity. These findings are descriptive, and the small sample size limits generalization. The presence of EBV in immunosuppressed individuals may suggest immunotoxic mechanisms affecting viral persistence in the skin. Further studies with larger cohorts are warranted.
- 2 October 2025
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 44 (4) , 579-586
Identification of human papillomavirus, Epstein–Barr virus and cytomegalovirus in paraffin tissues by molecular methods in patients with anogenital warts
Anogenital warts (AGWs) are typically caused by low-risk HPV types. Coinfection with EBV and CMV may influence disease progression, especially under immunosuppression. This study aimed to detect HPV, EBV, and CMV in tissue samples from AGW patients. This descriptive, retrospective, single-center study aimed to detect HPV, EBV, and CMV DNA in paraffin-embedded tissue samples from patients with AGWs. Paraffin-embedded tissues from 24 AGW patients were analyzed using real-time PCR and pyrosequencing for HPV, EBV, and CMV DNA. Demographic and viral data were statistically evaluated. Degraded or insufficient DNA samples were excluded following quality control assessment. Descriptive and comparative statistical analyses were performed using SPSS v22.0. HPV was detected in 62.5% of patients, most commonly type 6, followed by types 40, 87, and 16. EBV was found in 2 patients (8.3%), both with HPV coinfection. HPV. CMV was not detected in any samples. No statistically significant associations were found between demographic or clinical parameters and viral positivity. The study identified rare EBV and HPV coinfections in AGWs but no CMV positivity. These findings are descriptive, and the small sample size limits generalization. The presence of EBV in immunosuppressed individuals may suggest immunotoxic mechanisms affecting viral persistence in the skin. Further studies with larger cohorts are warranted.
- Open Access
- 13 February 2025
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (2) , 121
Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer
Background: Lung cancer remains the leading cause of cancer-related deaths worldwide, with non-small cell lung carcinomas (NSCLCs) comprising the majority of cases. Among the common driver mutations, KRAS plays a critical role in guiding treatment strategies. This study evaluates the expression of programmed death-ligand 1 (PD-L1) and hypoxia-inducible factor 1-alpha (HIF-1α) in KRAS-mutant NSCLCs and investigates their associations with clinicopathological findings. Methods: A total of 85 cases with KRAS mutations were analyzed. Immunohistochemical staining for HIF-1α and PD-L1 was performed, and their relationships with mutation status and prognostic variables were assessed. Results: A significant correlation was identified between HIF-1α expression and PD-L1 expression in tumor cells. While the KRAS G12C mutation was not significantly associated with HIF-1α expression in tumor cells, it demonstrated a notable relationship with HIF-1α expression in the tumor microenvironment and PD-L1 expression. However, PD-L1 and HIF-1α expression did not significantly influence overall survival outcomes. Conclusions: Expression of PD-L1 was positively correlated with HIF-1α, which may provide evidence for a novel therapy targeting PD-L1 and HIF-1α in NSCLC. Further comprehensive studies are warranted to elucidate the prognostic implications of tumor–microenvironment and mutation interactions.
- 13 February 2025
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (2) , 121
Open AccessCorrelation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer
Background: Lung cancer remains the leading cause of cancer-related deaths worldwide, with non-small cell lung carcinomas (NSCLCs) comprising the majority of cases. Among the common driver mutations, KRAS plays a critical role in guiding treatment strategies. This study evaluates the expression of programmed death-ligand 1 (PD-L1) and hypoxia-inducible factor 1-alpha (HIF-1α) in KRAS-mutant NSCLCs and investigates their associations with clinicopathological findings. Methods: A total of 85 cases with KRAS mutations were analyzed. Immunohistochemical staining for HIF-1α and PD-L1 was performed, and their relationships with mutation status and prognostic variables were assessed. Results: A significant correlation was identified between HIF-1α expression and PD-L1 expression in tumor cells. While the KRAS G12C mutation was not significantly associated with HIF-1α expression in tumor cells, it demonstrated a notable relationship with HIF-1α expression in the tumor microenvironment and PD-L1 expression. However, PD-L1 and HIF-1α expression did not significantly influence overall survival outcomes. Conclusions: Expression of PD-L1 was positively correlated with HIF-1α, which may provide evidence for a novel therapy targeting PD-L1 and HIF-1α in NSCLC. Further comprehensive studies are warranted to elucidate the prognostic implications of tumor–microenvironment and mutation interactions.
- Open Access
- 31 January 2024
- Published by LookUs Bilisim A.S. in Medical Records
- Vol. 6 (1) , 132-137
Inflammation Severity in Radicular Cysts and Its Relationship with Age and Gender
Aim: In this study, in radicular cyst cases in our department; It was aimed to evaluate the severity of inflammation (active and chronic inflammation) and to investigate its relationship with age and gender. Material and Method: Radicular cyst cases between 01.01.2013 and 31.01.2022 in Ordu University, Faculty of Medicine, Department of Pathology were included in the study. Ethical approval was taken from Ordu University Medical School, Clinical Trials Ethical Committee (2022/82). Preparations of the cases were found from the archive and examined microscopically to score the severity of inflammation. To examine any relationships that existed between categorical variables, Chi-square test was used. To determine any relationships between the score variables, correlation analysis was done. Results: A statistically significant moderate negative correlation was observed between age and chronicity in women (r=-0.410, p=0.013). A statistically significant moderate positive correlation was observed between activity and chronicity scores in men (r=0.592, p
- 31 January 2024
- Published by LookUs Bilisim A.S. in Medical Records
- Vol. 6 (1) , 132-137
Open AccessInflammation Severity in Radicular Cysts and Its Relationship with Age and Gender
Aim: In this study, in radicular cyst cases in our department; It was aimed to evaluate the severity of inflammation (active and chronic inflammation) and to investigate its relationship with age and gender. Material and Method: Radicular cyst cases between 01.01.2013 and 31.01.2022 in Ordu University, Faculty of Medicine, Department of Pathology were included in the study. Ethical approval was taken from Ordu University Medical School, Clinical Trials Ethical Committee (2022/82). Preparations of the cases were found from the archive and examined microscopically to score the severity of inflammation. To examine any relationships that existed between categorical variables, Chi-square test was used. To determine any relationships between the score variables, correlation analysis was done. Results: A statistically significant moderate negative correlation was observed between age and chronicity in women (r=-0.410, p=0.013). A statistically significant moderate positive correlation was observed between activity and chronicity scores in men (r=0.592, p
- 1 August 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (3) , 261-266
Wnt1 and β-Catenin Expression in Lobular Capillary Hemangioma: Immunohistochemical Study
- 1 August 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (3) , 261-266
Wnt1 and β-Catenin Expression in Lobular Capillary Hemangioma: Immunohistochemical Study
- Open Access
- 22 March 2023
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 13 (2) , 326-330
New proteins in the differentiation of papillary renal cell carcinoma from clear cell renal cell carcinomas; Importance of DARS2, Reelin and Enkurin
Purpose: The purpose of the present study was to examine the roles of new proteins DARS2, Reelin, and Encurin in the differentiation of Clear-Cell Renal Cell Carcinoma (RCC) and Papillary Renal Cell Carcinoma (RCC). Clear-cell RCC is the most common malignancy of the kidney, and papillary RCC is the second most common malignant malignancy in this respect. They are neoplasms and show similarity to each other, both histologically and morphologically, in some cases. Differential diagnosis is important because treatment approaches and prognoses are different. Although careful histopathological examination and specific immunohistochemical markers are important for diagnosis, there are no specific antibodies that can be used reliably and the search for biomarkers continues in this regard. Materials and Methods: A total of 30 Clear-Cell RCC and 30 Papillary RCC cases were included in the present study. Patients were identified retrospectively by reviewing the hospital database and pathological reports. Pathological data were obtained from hospital medical archives and pathology reports. Results: It was found that DARS2, Reelin, and Encurin proteins were significantly higher in papillary RCC when compared to clear-cell RCC. Conclusion: It was concluded that DARS2, Reelin, and Encurin proteins may be potential biomarkers for the differentiation of Papillary RCC and Clear-Cell RCC.
- 22 March 2023
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 13 (2) , 326-330
Open AccessNew proteins in the differentiation of papillary renal cell carcinoma from clear cell renal cell carcinomas; Importance of DARS2, Reelin and Enkurin
Purpose: The purpose of the present study was to examine the roles of new proteins DARS2, Reelin, and Encurin in the differentiation of Clear-Cell Renal Cell Carcinoma (RCC) and Papillary Renal Cell Carcinoma (RCC). Clear-cell RCC is the most common malignancy of the kidney, and papillary RCC is the second most common malignant malignancy in this respect. They are neoplasms and show similarity to each other, both histologically and morphologically, in some cases. Differential diagnosis is important because treatment approaches and prognoses are different. Although careful histopathological examination and specific immunohistochemical markers are important for diagnosis, there are no specific antibodies that can be used reliably and the search for biomarkers continues in this regard. Materials and Methods: A total of 30 Clear-Cell RCC and 30 Papillary RCC cases were included in the present study. Patients were identified retrospectively by reviewing the hospital database and pathological reports. Pathological data were obtained from hospital medical archives and pathology reports. Results: It was found that DARS2, Reelin, and Encurin proteins were significantly higher in papillary RCC when compared to clear-cell RCC. Conclusion: It was concluded that DARS2, Reelin, and Encurin proteins may be potential biomarkers for the differentiation of Papillary RCC and Clear-Cell RCC.
- Open Access
- 9 February 2023
- Published by SelSistem in Journal of Surgery and Medicine
- Vol. 7 (3) , 00
New biomarkers for differentiating renal neoplasms with eosinophilic cytoplasm: DARS2, reelin, and enkurin
Background/Aim: Chromophobe renal cell carcinoma (CRCC), eosinophilic variant clear cell RCC, and oncocytomas are renal neoplasms with eosinophilic cytoplasm, and their differential diagnosis is challenging despite significant advances in molecular pathology. Although many biomarkers have been identified for the differential diagnosis of these neoplasms, specific markers have not yet been reported. No studies were found in the literature on the relationship between these tumors and the new molecules DARS2, reelin, and enkurin. This paper aims to determine the roles of these proteins in renal neoplasms with eosinophilic cytoplasm. Methods: The study retrospectively analyzed 30 EC RCC, 30 CRCC, and 30 oncocytoma cases, evaluated among renal neoplasms with eosinophilic cytoplasm, independent of demographic characteristics, in the Fırat University Medical Pathology Laboratory between 2012 and 2022. The most representative samples of the tumor were selected for each group, and the expression of DARS2, reelin, and enkurin proteins was evaluated by the immunohistochemical method. Results: The histoscore of DARS2 expression was highest in EC RCC and least in CRCC. DARS2 was seen to differentiate CRCC from oncocytoma and EC RCC. The histoscore of reelin and enkurin protein expression was highest in oncocytoma and lowest in ECRCC. The difference between the groups was statistically significant (PConclusion: DARS2 can be a useful biomarker for differentiating CRCC from EC RCC and oncocytoma, and enkurin and reelin can differentiate among these three groups. '+st+' Pathology Histology Embryology Pathology Motzer RJ, Jonasch E, Agarwal N, et al. Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(6):804–34. DOI: https://doi.org/10.6004/jnccn.2017.0100 Lam JS, Klatte T, Kim HL, et al. Prognostic factors and selection for clinical studies of patients with kidney cancer. Crit Rev Oncol Hematol. 2008;65(3):235–62. DOI: https://doi.org/10.1016/j.critrevonc.2007.08.003 Eichelberg C, Junker K, Ljungberg B, Moch H. Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. Eur Urol. 2009;55(4):851–63. DOI: https://doi.org/10.1016/j.eururo.2009.01.003 Grignon DJ, Che M. Clear cell renal cell carcinoma. Clin Lab Med. 2005;25(2):305–16. DOI: https://doi.org/10.1016/j.cll.2005.01.012 Moch H, Ohashi R. Chromophobe renal cell carcinoma: current and controversial issues. Pathology. 2021;53(1):101–8. DOI: https://doi.org/10.1016/j.pathol.2020.09.015 Kuroda N, Kanomata N, Yamaguchi T, Imamura, et al. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma. Med Mol Morphol. 2011;44(2):111–5. DOI: https://doi.org/10.1007/s00795-009-0461-z Akgul M, Williamson SR. Immunohistochemistry for the diagnosis of renal epithelial neoplasms. Semin Diagn Pathol. 2022;39(1):1–16. DOI: https://doi.org/10.1053/j.semdp.2021.11.001 Gasparre G, Romeo G, Rugolo M, Porcelli AM. Learning from oncocytic tumors: Why choose inefficient mitochondria? Biochim Biophys Acta. 2011;1807(6):633–42. DOI: https://doi.org/10.1016/j.bbabio.2010.08.006 Leibovich BC, Lohse CM, Crispen PL, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J urol. 2010;183(4):1309–15. DOI: https://doi.org/10.1016/j.juro.2009.12.035 Gakis G, Kramer U, Schilling D, Kruck, et al. Small renal oncocytomas: differentiation with multiphase CT. Eur J Radiol. 2011;80(2):274–8. DOI: https://doi.org/10.1016/j.ejrad.2010.06.049 Zhang X, Dong W, Zhang J, et al. A Novel Mitochondrial-Related Nuclear Gene Signature Predicts Overall Survival of Lung Adenocarcinoma Patients. Front Cell Dev Biol. 2021;9:740487. DOI: https://doi.org/10.3389/fcell.2021.740487 Khialeeva E, Lane TF, Carpenter EM. Disruption of reelin signaling alters mammary gland morphogenesis. Development. 2011;138(4):767–76. DOI: https://doi.org/10.1242/dev.057588 Hou R, Liu X, Yang H, et al. Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression. Cancer Lett. 2022;531:57–70. DOI: https://doi.org/10.1016/j.canlet.2022.01.025 Kocaman N, Artaş G. Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma? Biotech Histochem. 2020;95(3):171–5. DOI: https://doi.org/10.1080/10520295.2019.1656344 Pan CC, Chen PC, Chiang H. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol. 2004;121(6):878–83. DOI: https://doi.org/10.1309/A7M2XTMJQK0KPQER Yu YC, Han JM, Kim S. Aminoacyl-tRNA synthetases and amino acid signaling. Biochim Biophys Acta Mol Cell Res. 2021;1868(1):118889. DOI: https://doi.org/10.1016/j.bbamcr.2020.118889 Van Berge L, Hamilton EM, Linnankivi T, et al. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy. Brain. 2014;137(4):1019–29. DOI: https://doi.org/10.1093/brain/awu026 Guo C, Shao T, Jiang X, et al. Comprehensive analysis of the functions and prognostic significance of RNA-binding proteins in bladder urothelial carcinoma. Am J Transl Res. 2020; 12(11):7160–73. DOI: https://doi.org/10.21203/rs.3.rs-44292/v1 Wang J, Zhao X, Wang Y, et al. circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis. 2020;11(1):32. DOI: https://doi.org/10.1038/s41419-020-2230-9 Ucer O, Kocaman N. New candidates in the differential diagnosis of malignant mesothelioma from benign mesothelial hyperplasia and adenocarcinoma; DARS2 and suprabasin. Tissue & cell. 2022;79:101920. DOI: https://doi.org/10.1016/j.tice.2022.101920 Chen F, Wang Q, Zhou Y. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer. BMC cancer. 2021;21(1):244. DOI: https://doi.org/10.1186/s12885-021-07930-5 Casuscelli J, Weinhold N, Gundem G, Wang Let al. Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma. JCI insight. 2017;2(12):92688. DOI: https://doi.org/10.1172/jci.insight.92688 Gabriella DA. Reelin in the Years: Controlling Neuronal Migration and Maturation in the Mammalian Brain Hunting. Neurosci. 2014;2014:1–19. DOI: https://doi.org/10.1155/2014/597395 Khialeeva E, Carpenter EM. Non-neuronal roles for the reelin signaling pathway. Dev Dyn. 2017;246(4):217–26. DOI: https://doi.org/10.1002/dvdy.24462 Stein T, Cosimo E, Yu X, et al. Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis. Am J Pathol. 2010;177(5):2323–33. DOI: https://doi.org/10.2353/ajpath.2010.100209 Sutton KA, Jungnickel MK, Wang Y, et al. Enkurin is a novel calmodulin and TRPC channel binding protein in sperm. Dev Biol. 2004;274(2):426–35. DOI: https://doi.org/10.1016/j.ydbio.2004.07.031 Ma Q, Lu Y, Gu Y. ENKUR Is Involved in the Regulation of Cellular Biology in Colorectal Cancer Cells via PI3K/Akt Signaling Pathway. Technol Cancer Res Treat. 2019;18:1533033819841433. DOI: https://doi.org/10.1177/1533033819841433 Ma Q, Lu Y, Lin J, et al. ENKUR acts as a tumor suppressor in lung adenocarcinoma cells through PI3K/Akt and MAPK/ERK signaling pathways. J Cancer. 2019;10(17):3975–84. DOI: https://doi.org/10.7150/jca.30021 Song T, Zhou P, Sun C, et al. Enkurin domain containing 1 (ENKD1) regulates the proliferation, migration and invasion of non-small cell lung cancer cells. Asia Pac J Clin Oncol. 2022;18(2):39–45. DOI: https://doi.org/10.1111/ajco.13550 Copyright (c) 2023 Hilal Balta, Nevin Kocaman, Ozlem Ucer This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
- 9 February 2023
- Published by SelSistem in Journal of Surgery and Medicine
- Vol. 7 (3) , 00
Open AccessNew biomarkers for differentiating renal neoplasms with eosinophilic cytoplasm: DARS2, reelin, and enkurin
Background/Aim: Chromophobe renal cell carcinoma (CRCC), eosinophilic variant clear cell RCC, and oncocytomas are renal neoplasms with eosinophilic cytoplasm, and their differential diagnosis is challenging despite significant advances in molecular pathology. Although many biomarkers have been identified for the differential diagnosis of these neoplasms, specific markers have not yet been reported. No studies were found in the literature on the relationship between these tumors and the new molecules DARS2, reelin, and enkurin. This paper aims to determine the roles of these proteins in renal neoplasms with eosinophilic cytoplasm. Methods: The study retrospectively analyzed 30 EC RCC, 30 CRCC, and 30 oncocytoma cases, evaluated among renal neoplasms with eosinophilic cytoplasm, independent of demographic characteristics, in the Fırat University Medical Pathology Laboratory between 2012 and 2022. The most representative samples of the tumor were selected for each group, and the expression of DARS2, reelin, and enkurin proteins was evaluated by the immunohistochemical method. Results: The histoscore of DARS2 expression was highest in EC RCC and least in CRCC. DARS2 was seen to differentiate CRCC from oncocytoma and EC RCC. The histoscore of reelin and enkurin protein expression was highest in oncocytoma and lowest in ECRCC. The difference between the groups was statistically significant (PConclusion: DARS2 can be a useful biomarker for differentiating CRCC from EC RCC and oncocytoma, and enkurin and reelin can differentiate among these three groups. '+st+' Pathology Histology Embryology Pathology Motzer RJ, Jonasch E, Agarwal N, et al. Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(6):804–34. DOI: https://doi.org/10.6004/jnccn.2017.0100 Lam JS, Klatte T, Kim HL, et al. Prognostic factors and selection for clinical studies of patients with kidney cancer. Crit Rev Oncol Hematol. 2008;65(3):235–62. DOI: https://doi.org/10.1016/j.critrevonc.2007.08.003 Eichelberg C, Junker K, Ljungberg B, Moch H. Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. Eur Urol. 2009;55(4):851–63. DOI: https://doi.org/10.1016/j.eururo.2009.01.003 Grignon DJ, Che M. Clear cell renal cell carcinoma. Clin Lab Med. 2005;25(2):305–16. DOI: https://doi.org/10.1016/j.cll.2005.01.012 Moch H, Ohashi R. Chromophobe renal cell carcinoma: current and controversial issues. Pathology. 2021;53(1):101–8. DOI: https://doi.org/10.1016/j.pathol.2020.09.015 Kuroda N, Kanomata N, Yamaguchi T, Imamura, et al. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma. Med Mol Morphol. 2011;44(2):111–5. DOI: https://doi.org/10.1007/s00795-009-0461-z Akgul M, Williamson SR. Immunohistochemistry for the diagnosis of renal epithelial neoplasms. Semin Diagn Pathol. 2022;39(1):1–16. DOI: https://doi.org/10.1053/j.semdp.2021.11.001 Gasparre G, Romeo G, Rugolo M, Porcelli AM. Learning from oncocytic tumors: Why choose inefficient mitochondria? Biochim Biophys Acta. 2011;1807(6):633–42. DOI: https://doi.org/10.1016/j.bbabio.2010.08.006 Leibovich BC, Lohse CM, Crispen PL, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J urol. 2010;183(4):1309–15. DOI: https://doi.org/10.1016/j.juro.2009.12.035 Gakis G, Kramer U, Schilling D, Kruck, et al. Small renal oncocytomas: differentiation with multiphase CT. Eur J Radiol. 2011;80(2):274–8. DOI: https://doi.org/10.1016/j.ejrad.2010.06.049 Zhang X, Dong W, Zhang J, et al. A Novel Mitochondrial-Related Nuclear Gene Signature Predicts Overall Survival of Lung Adenocarcinoma Patients. Front Cell Dev Biol. 2021;9:740487. DOI: https://doi.org/10.3389/fcell.2021.740487 Khialeeva E, Lane TF, Carpenter EM. Disruption of reelin signaling alters mammary gland morphogenesis. Development. 2011;138(4):767–76. DOI: https://doi.org/10.1242/dev.057588 Hou R, Liu X, Yang H, et al. Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression. Cancer Lett. 2022;531:57–70. DOI: https://doi.org/10.1016/j.canlet.2022.01.025 Kocaman N, Artaş G. Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma? Biotech Histochem. 2020;95(3):171–5. DOI: https://doi.org/10.1080/10520295.2019.1656344 Pan CC, Chen PC, Chiang H. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol. 2004;121(6):878–83. DOI: https://doi.org/10.1309/A7M2XTMJQK0KPQER Yu YC, Han JM, Kim S. Aminoacyl-tRNA synthetases and amino acid signaling. Biochim Biophys Acta Mol Cell Res. 2021;1868(1):118889. DOI: https://doi.org/10.1016/j.bbamcr.2020.118889 Van Berge L, Hamilton EM, Linnankivi T, et al. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy. Brain. 2014;137(4):1019–29. DOI: https://doi.org/10.1093/brain/awu026 Guo C, Shao T, Jiang X, et al. Comprehensive analysis of the functions and prognostic significance of RNA-binding proteins in bladder urothelial carcinoma. Am J Transl Res. 2020; 12(11):7160–73. DOI: https://doi.org/10.21203/rs.3.rs-44292/v1 Wang J, Zhao X, Wang Y, et al. circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis. 2020;11(1):32. DOI: https://doi.org/10.1038/s41419-020-2230-9 Ucer O, Kocaman N. New candidates in the differential diagnosis of malignant mesothelioma from benign mesothelial hyperplasia and adenocarcinoma; DARS2 and suprabasin. Tissue & cell. 2022;79:101920. DOI: https://doi.org/10.1016/j.tice.2022.101920 Chen F, Wang Q, Zhou Y. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer. BMC cancer. 2021;21(1):244. DOI: https://doi.org/10.1186/s12885-021-07930-5 Casuscelli J, Weinhold N, Gundem G, Wang Let al. Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma. JCI insight. 2017;2(12):92688. DOI: https://doi.org/10.1172/jci.insight.92688 Gabriella DA. Reelin in the Years: Controlling Neuronal Migration and Maturation in the Mammalian Brain Hunting. Neurosci. 2014;2014:1–19. DOI: https://doi.org/10.1155/2014/597395 Khialeeva E, Carpenter EM. Non-neuronal roles for the reelin signaling pathway. Dev Dyn. 2017;246(4):217–26. DOI: https://doi.org/10.1002/dvdy.24462 Stein T, Cosimo E, Yu X, et al. Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis. Am J Pathol. 2010;177(5):2323–33. DOI: https://doi.org/10.2353/ajpath.2010.100209 Sutton KA, Jungnickel MK, Wang Y, et al. Enkurin is a novel calmodulin and TRPC channel binding protein in sperm. Dev Biol. 2004;274(2):426–35. DOI: https://doi.org/10.1016/j.ydbio.2004.07.031 Ma Q, Lu Y, Gu Y. ENKUR Is Involved in the Regulation of Cellular Biology in Colorectal Cancer Cells via PI3K/Akt Signaling Pathway. Technol Cancer Res Treat. 2019;18:1533033819841433. DOI: https://doi.org/10.1177/1533033819841433 Ma Q, Lu Y, Lin J, et al. ENKUR acts as a tumor suppressor in lung adenocarcinoma cells through PI3K/Akt and MAPK/ERK signaling pathways. J Cancer. 2019;10(17):3975–84. DOI: https://doi.org/10.7150/jca.30021 Song T, Zhou P, Sun C, et al. Enkurin domain containing 1 (ENKD1) regulates the proliferation, migration and invasion of non-small cell lung cancer cells. Asia Pac J Clin Oncol. 2022;18(2):39–45. DOI: https://doi.org/10.1111/ajco.13550 Copyright (c) 2023 Hilal Balta, Nevin Kocaman, Ozlem Ucer This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
- 1 October 2022
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 18 (4) , 371-374
Co-Existence of Two Rare Entities in the Male Breast: Intraductal Papilloma and Angiolipoma
Intraductal papilloma and angiolipoma lesions are very rare in male breasts and gynecomastia is the most common male breast pathology.
- 1 October 2022
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 18 (4) , 371-374
Co-Existence of Two Rare Entities in the Male Breast: Intraductal Papilloma and Angiolipoma
Intraductal papilloma and angiolipoma lesions are very rare in male breasts and gynecomastia is the most common male breast pathology.
- 1 September 2022
- Published by Ordu University in Black Sea Journal of Health Science
- Vol. 5 (3) , 490-492
Patient Characteristics, Locations and Histopathological Features of Steatocystoma Multiplex Cases
Steatocystoma multiplex (SM) is a rare benign genetic disorder consisted of multiple cystic with little or no nail and hair involvement. Steatocystoma is a hamartomatous malformation of the pilosebaceous unit consisting of dermal cysts filled with a sebum-like material. To examine the patient characteristics, locations, presentations and histopathological features of SM in a group of patients. We analyzed 9 patients retrospectively that histopathologically diagnosed as SM. Demographic data collected from pathology reports. Patients’ mean age was 43.7 years (range: 15-69 years), with a male to female ratio of 7:2. The average diameter of the lesion at presentation was 13.2 mm (range: 2–30 mm), although 4 cases were less than or equal to 5 mm in size. The lesions located in neck, conjuctiva, face and frontal region. The most common clinical presentation was a painless skin lesion which was noticed incidentally. Histopathological examination of skin showed presence of cystic formation with sebaceous gland on its wall in the dermis and typical stratified squamous epithelium that showed wavy shaped stratum corneum, refractile and strong eosinophilic infiltrated in the cystic wall. SMs are benign lesions more frequent in male patients and especially located in head and neck region. These lesions may be misdiagnosed or underreported.
- 1 September 2022
- Published by Ordu University in Black Sea Journal of Health Science
- Vol. 5 (3) , 490-492
Patient Characteristics, Locations and Histopathological Features of Steatocystoma Multiplex Cases
Steatocystoma multiplex (SM) is a rare benign genetic disorder consisted of multiple cystic with little or no nail and hair involvement. Steatocystoma is a hamartomatous malformation of the pilosebaceous unit consisting of dermal cysts filled with a sebum-like material. To examine the patient characteristics, locations, presentations and histopathological features of SM in a group of patients. We analyzed 9 patients retrospectively that histopathologically diagnosed as SM. Demographic data collected from pathology reports. Patients’ mean age was 43.7 years (range: 15-69 years), with a male to female ratio of 7:2. The average diameter of the lesion at presentation was 13.2 mm (range: 2–30 mm), although 4 cases were less than or equal to 5 mm in size. The lesions located in neck, conjuctiva, face and frontal region. The most common clinical presentation was a painless skin lesion which was noticed incidentally. Histopathological examination of skin showed presence of cystic formation with sebaceous gland on its wall in the dermis and typical stratified squamous epithelium that showed wavy shaped stratum corneum, refractile and strong eosinophilic infiltrated in the cystic wall. SMs are benign lesions more frequent in male patients and especially located in head and neck region. These lesions may be misdiagnosed or underreported.
- Open Access
- 1 January 2016
- Published by Galenos Yayinevi in Journal of Dr Behcet Uz Children s Hospital
Histopathological frequency of Helicobacter pylori in children between 1-18 ages in the Erzurum province
- 1 January 2016
- Published by Galenos Yayinevi in Journal of Dr Behcet Uz Children s Hospital
Open AccessHistopathological frequency of Helicobacter pylori in children between 1-18 ages in the Erzurum province